CN103435557A - 5-氟胞嘧啶的制备方法 - Google Patents
5-氟胞嘧啶的制备方法 Download PDFInfo
- Publication number
- CN103435557A CN103435557A CN2013103431870A CN201310343187A CN103435557A CN 103435557 A CN103435557 A CN 103435557A CN 2013103431870 A CN2013103431870 A CN 2013103431870A CN 201310343187 A CN201310343187 A CN 201310343187A CN 103435557 A CN103435557 A CN 103435557A
- Authority
- CN
- China
- Prior art keywords
- reaction
- flurocytosine
- preparation
- temperature
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 title claims abstract description 66
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229960004413 flucytosine Drugs 0.000 title claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 67
- 238000000034 method Methods 0.000 claims abstract description 47
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims abstract description 40
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims abstract description 20
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims abstract description 20
- RJBYSQHLLIHSLT-UHFFFAOYSA-N methyl 2-fluoroacetate Chemical compound COC(=O)CF RJBYSQHLLIHSLT-UHFFFAOYSA-N 0.000 claims abstract description 20
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000004202 carbamide Substances 0.000 claims abstract description 14
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000005660 chlorination reaction Methods 0.000 claims abstract description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000006482 condensation reaction Methods 0.000 claims abstract description 3
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- 238000003756 stirring Methods 0.000 claims description 33
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 23
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 21
- 239000007787 solid Substances 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 238000004821 distillation Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 6
- 238000001953 recrystallisation Methods 0.000 claims description 6
- 238000010792 warming Methods 0.000 claims description 6
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000001117 sulphuric acid Substances 0.000 claims description 3
- 235000011149 sulphuric acid Nutrition 0.000 claims description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 2
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 239000000908 ammonium hydroxide Substances 0.000 abstract 1
- 238000005915 ammonolysis reaction Methods 0.000 abstract 1
- 231100000481 chemical toxicant Toxicity 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000012805 post-processing Methods 0.000 abstract 1
- 238000001308 synthesis method Methods 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 abstract 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 29
- 229960002949 fluorouracil Drugs 0.000 description 28
- 238000004128 high performance liquid chromatography Methods 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 230000006837 decompression Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 5
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940104230 thymidine Drugs 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010055113 Breast cancer metastatic Diseases 0.000 description 1
- GPEQXBCPWPJONW-UHFFFAOYSA-N CC(C=NC=C1C)N=C1N Chemical compound CC(C=NC=C1C)N=C1N GPEQXBCPWPJONW-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WHPFEQUEHBULBW-UHFFFAOYSA-N Fc(cnc(Cl)n1)c1Cl Chemical compound Fc(cnc(Cl)n1)c1Cl WHPFEQUEHBULBW-UHFFFAOYSA-N 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- IHLQCKDJOGRTEA-GJYVGRRXSA-N N/C=C(\C/C(/Cl)=N\CCl)/F Chemical compound N/C=C(\C/C(/Cl)=N\CCl)/F IHLQCKDJOGRTEA-GJYVGRRXSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 238000004176 ammonification Methods 0.000 description 1
- 230000001399 anti-metabolic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- -1 methoxyl group Chemical group 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310343187.0A CN103435557B (zh) | 2013-08-08 | 2013-08-08 | 5-氟胞嘧啶的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310343187.0A CN103435557B (zh) | 2013-08-08 | 2013-08-08 | 5-氟胞嘧啶的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103435557A true CN103435557A (zh) | 2013-12-11 |
CN103435557B CN103435557B (zh) | 2015-05-20 |
Family
ID=49689302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310343187.0A Active CN103435557B (zh) | 2013-08-08 | 2013-08-08 | 5-氟胞嘧啶的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103435557B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104447576A (zh) * | 2014-11-21 | 2015-03-25 | 山东金城医药化工股份有限公司 | 5-氟尿嘧啶的制备方法 |
CN105153041A (zh) * | 2015-10-20 | 2015-12-16 | 浙江先锋科技股份有限公司 | 一种适用于工业化生产的5-氟胞嘧啶的制备方法 |
CN106632080A (zh) * | 2016-08-25 | 2017-05-10 | 宿迁市万和泰化工有限公司 | 一种氟胞嘧啶的生产工艺 |
CN107793364A (zh) * | 2017-12-01 | 2018-03-13 | 新乡拓新药业股份有限公司 | 一种合成5‑氟胞嘧啶的方法 |
CN108033917A (zh) * | 2017-12-15 | 2018-05-15 | 浙江先锋科技股份有限公司 | 一种5-氟胞嘧啶的制备方法 |
CN110105290A (zh) * | 2019-05-14 | 2019-08-09 | 浙江伟锋药业有限公司 | 一种5-氟胞嘧啶的制备方法 |
CN111995583A (zh) * | 2020-08-18 | 2020-11-27 | 上海毕得医药科技有限公司 | 一种1,5-二甲基嘧啶-2(1h)-酮的合成方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53108983A (en) * | 1977-02-28 | 1978-09-22 | Wako Pure Chem Ind Ltd | Preparation of 5-fluorouracil |
JPH08127569A (ja) * | 1994-10-31 | 1996-05-21 | Sumika Fine Chem Kk | フルシトシンの製造方法 |
CN101646673A (zh) * | 2007-02-07 | 2010-02-10 | 辉瑞大药厂 | 作为pkc抑制剂的3-氨基-吡咯并[3,4-c]吡唑-5(1h,4h,6h)甲醛衍生物 |
-
2013
- 2013-08-08 CN CN201310343187.0A patent/CN103435557B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53108983A (en) * | 1977-02-28 | 1978-09-22 | Wako Pure Chem Ind Ltd | Preparation of 5-fluorouracil |
JPH08127569A (ja) * | 1994-10-31 | 1996-05-21 | Sumika Fine Chem Kk | フルシトシンの製造方法 |
CN101646673A (zh) * | 2007-02-07 | 2010-02-10 | 辉瑞大药厂 | 作为pkc抑制剂的3-氨基-吡咯并[3,4-c]吡唑-5(1h,4h,6h)甲醛衍生物 |
Non-Patent Citations (2)
Title |
---|
张奕华: "氟胞嘧啶合成工艺的改进", 《中国药科大学学报》, vol. 20, no. 1, 31 December 1989 (1989-12-31), pages 35 - 36 * |
钟光祥: "5-氟尿嘧啶的合成方法述评", 《浙江化工》, vol. 26, no. 1, 31 December 1995 (1995-12-31) * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104447576A (zh) * | 2014-11-21 | 2015-03-25 | 山东金城医药化工股份有限公司 | 5-氟尿嘧啶的制备方法 |
CN105153041A (zh) * | 2015-10-20 | 2015-12-16 | 浙江先锋科技股份有限公司 | 一种适用于工业化生产的5-氟胞嘧啶的制备方法 |
CN106632080A (zh) * | 2016-08-25 | 2017-05-10 | 宿迁市万和泰化工有限公司 | 一种氟胞嘧啶的生产工艺 |
CN107793364A (zh) * | 2017-12-01 | 2018-03-13 | 新乡拓新药业股份有限公司 | 一种合成5‑氟胞嘧啶的方法 |
CN108033917A (zh) * | 2017-12-15 | 2018-05-15 | 浙江先锋科技股份有限公司 | 一种5-氟胞嘧啶的制备方法 |
CN108033917B (zh) * | 2017-12-15 | 2019-12-10 | 浙江先锋科技股份有限公司 | 一种5-氟胞嘧啶的制备方法 |
CN110105290A (zh) * | 2019-05-14 | 2019-08-09 | 浙江伟锋药业有限公司 | 一种5-氟胞嘧啶的制备方法 |
CN110105290B (zh) * | 2019-05-14 | 2020-06-23 | 浙江伟锋药业有限公司 | 一种5-氟胞嘧啶的制备方法 |
CN111995583A (zh) * | 2020-08-18 | 2020-11-27 | 上海毕得医药科技有限公司 | 一种1,5-二甲基嘧啶-2(1h)-酮的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103435557B (zh) | 2015-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103435557B (zh) | 5-氟胞嘧啶的制备方法 | |
CN104725327B (zh) | 一种盐酸厄洛替尼的环保制备方法 | |
CN104496917B (zh) | 一种法匹拉韦的合成方法 | |
CN102079725B (zh) | 一种制备2-氯嘧啶的方法 | |
CN102584795B (zh) | 一种克里唑替尼的制备方法 | |
CN107312003A (zh) | 一种制备高纯度2‑氨基‑6‑氯鸟嘌呤的合成方法 | |
CN103923019A (zh) | 2-羟基-4-氨基-5-氟嘧啶的制备方法 | |
CN103570633B (zh) | 吉非替尼的制备方法 | |
CN105566215A (zh) | 一种瑞戈非尼的制备方法 | |
CN105153149B (zh) | 一种选择性激酶抑制剂Palbociclib的制备方法 | |
CN105111197A (zh) | 雷替曲塞的合成方法 | |
CN108033917A (zh) | 一种5-氟胞嘧啶的制备方法 | |
CN102924380A (zh) | 一种咪唑苯脲的制备方法 | |
CN103965191A (zh) | 一种6-溴咪唑并[1,2-a]吡啶-3-甲酸的合成方法 | |
CN103896858B (zh) | 胞嘧啶的制备工艺 | |
CN103626697B (zh) | 一种2‑氯‑4‑三氟甲基‑3‑氰基吡啶的制备方法 | |
CN105111103A (zh) | 邻羟基苯甲腈及其衍生物的制备方法 | |
CN105130909A (zh) | 一种2-氨基-4,6-二甲氧基嘧啶的制备方法 | |
CN104193638A (zh) | 一种制备(s)-2`,6`-二甲基酪氨酸及其衍生物的方法及所述衍生物 | |
CN106632280A (zh) | 一种制备盐酸阿呋唑嗪的方法 | |
CN106810546A (zh) | 一种芜地溴铵化合物 | |
CN105153041B (zh) | 一种适用于工业化生产的5‑氟胞嘧啶的制备方法 | |
CN108912016A (zh) | 一种制备n-苄氧羰基-l-缬氨酸的方法 | |
CN103351346A (zh) | 盐酸苯达莫司汀杂质hp1的制备方法 | |
CN115557904A (zh) | 一种适合规模生产5,7-双(三氟甲基)喹唑啉-2,4-二酮的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: Wenjiang District 610000 of Sichuan city of Chengdu province Chengdu Strait science and Technology Industry Development Park No. 488 West Ke Lin Lu Patentee after: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp. Address before: Ke Lin Lu Xi Duan cross-strait science and Technology Industrial Development Park in Wenjiang District of Chengdu City, Sichuan Province, No. 488 611137 Patentee before: AstaTech (Chengdu) Pharmaceutical Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: 5-fluorocytosine preparation method Effective date of registration: 20170822 Granted publication date: 20150520 Pledgee: Chengdu SME financing Company Limited by Guarantee Pledgor: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp. Registration number: 2017510000052 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180801 Granted publication date: 20150520 Pledgee: Chengdu SME financing Company Limited by Guarantee Pledgor: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp. Registration number: 2017510000052 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200820 Address after: Wenjiang District 610000 of Sichuan city of Chengdu province Chengdu Strait science and Technology Industry Development Park No. 488 West Ke Lin Lu Co-patentee after: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. Patentee after: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp. Address before: Wenjiang District 610000 of Sichuan city of Chengdu province Chengdu Strait science and Technology Industry Development Park No. 488 West Ke Lin Lu Patentee before: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220930 Address after: No. 488, west section of Kelin Road, Chengdu cross strait science and Technology Industrial Development Park, Wenjiang District, Chengdu, Sichuan 610000 Patentee after: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp. Address before: No. 488, west section of Kelin Road, Chengdu cross strait science and Technology Industrial Development Park, Wenjiang District, Chengdu, Sichuan 610000 Patentee before: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp. Patentee before: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |